Education
About Us
Working with TipRanks
Follow Us
Impedimed Limited (IPDQF)
OTHER OTC:IPDQF
Total Valuation
Impedimed Limited has a market cap or net worth of $27.45M. The enterprise value is $22.89M.
Market Cap$27.45M
Enterprise Value$22.89M
Share Statistics
Impedimed Limited has 2,038,747,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,038,747,700
Owned by Insiders0.74%
Owned by Institutions<0.01%
Financial Efficiency
Impedimed Limited’s return on equity (ROE) is -1.13 and return on invested capital (ROIC) is -66.82%.
Return on Equity (ROE)-1.13
Return on Assets (ROA)-0.56
Return on Invested Capital (ROIC)-66.82%
Return on Capital Employed (ROCE)-0.67
Revenue Per Employee153.30K
Profits Per Employee0.00
Employee Count83
Asset Turnover0.31
Inventory Turnover2.03
Valuation Ratios
The current PE Ratio of Impedimed Limited is ―. Impedimed Limited’s PEG ratio is -0.20.
PE Ratio―
PS Ratio5.55
PB Ratio3.45
Price to Fair Value3.45
Price to FCF-4.52
Price to Operating Cash Flow-2.52
PEG Ratio-0.20
Income Statement
In the last 12 months, Impedimed Limited had revenue of 12.72M and earned -23.24M in profits. Earnings per share was -0.01.
Revenue12.72M
Gross Profit10.97M
Operating Income-24.23M
Pretax Income-23.21M
Net Income-23.24M
EBITDA-17.55M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -15.22M and capital expenditures -60.00K, giving a free cash flow of -15.28M billion.
Operating Cash Flow-15.22M
Free Cash Flow-15.28M
Free Cash Flow per Share>-0.01
Dividends & Yields
Impedimed Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.02
52-Week Price Change-57.50%
50-Day Moving Average0.02
200-Day Moving Average0.02
Relative Strength Index (RSI)46.41
Average Volume (3m)5.35K
Important Dates
Impedimed Limited upcoming earnings date is Feb 20, 2026, TBA (Confirmed).
Last Earnings DateOct 30, 2025
Next Earnings DateFeb 20, 2026
Ex-Dividend Date―
Financial Position
Impedimed Limited as a current ratio of 4.86, with Debt / Equity ratio of 70.70%
Current Ratio4.86
Quick Ratio4.71
Debt to Market Cap0.20
Net Debt to EBITDA0.44
Interest Coverage Ratio-22.15
Taxes
In the past 12 months, Impedimed Limited has paid 26.00K in taxes.
Income Tax26.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Impedimed Limited EV to EBITDA ratio is -3.59, with an EV/FCF ratio of -4.03.
EV to Sales4.95
EV to EBITDA-3.59
EV to Free Cash Flow-4.03
EV to Operating Cash Flow-4.30
Balance Sheet
Impedimed Limited has $22.18M in cash and marketable securities with $14.49M in debt, giving a net cash position of $7.69M billion.
Cash & Marketable Securities$22.18M
Total Debt$14.49M
Net Cash$7.69M
Net Cash Per Share<$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 86.25%, with operating margin of -190.44%, and net profit margin of -182.62%.
Gross Margin86.25%
Operating Margin-190.44%
Pretax Margin-182.42%
Net Profit Margin-182.62%
EBITDA Margin-137.95%
EBIT Margin-173.82%
Analyst Forecast
The average price target for Impedimed Limited is $0.05, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$0.05
Price Target Upside136.22% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―